CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma

Overview of attention for article published in Respiratory Research, October 2020

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 112 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Spanish Consensus on Remission in Asthma (REMAS)

Article in Archivos de Bronconeumología (April 2024)

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

Article in Journal of Asthma and Allergy (March 2024)

Targeted and Biologic Therapeutics for Allergic and Immunologic Diseases

Book chapter (January 2024)